Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Rein Therapeutics, Inc.

NASDAQ: RNTX · Life Sciences · 2 alerts · CIK 1420565

Share price
$0.4000Close, Nov 16
Market cap
$34.5M
Shares outstanding
86.27MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Rein Therapeutics, Inc. filings on SEC EDGAR ↗

6:41 AM ET 10-Q
Financial Results

Rein Therapeutics Q3 2026 Results: Net Loss of $5.54M, Loss Narrows

Rein Therapeutics reported a net loss of $17.8 million for the nine months ended September 30, 2026, compared to $17.9 million in the prior year. The company significantly strengthened its balance sheet through common stock issuances, ending the period with $35.5 million in cash and short-term investments compared to $3.2 million at the end of 2025.

Key figure
Net loss $5.54M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.